Skip to content
info@ibsgranada.es
FacebookTwitterLinkedInInstagramYouTube
ibs logo.GRANADA
  • ibs.GRANADA
  • The Institute
    • The Institute
    • Organizational structure
    • Management Units
    • Economic information
    • Centers
    • Responsible Research and Innovation (RRI)
    • Researcher Area
    • Annual Reports ibs.GRANADA
    • Webmail access
    • Transparency
    • Partners
  • Research
    • Own Plan ibs.GRANADA
    • Research Areas
    • Research groups
    • Clinical research
    • Collaboration network between groups of the ibs.GRANADA
    • Researcher Finder
    • Publications Search
  • Innovation
    • Innovation
    • Technology Offers
    • Clinical practice guidelines
  • International
    • International Projects Unit
    • International Projects
    • International Networks
  • Training
    • Training
    • Research Sessions
    • Conferences and Courses
    • Mentoring Program ibs.GRANADA
    • PhD Programs
    • Official University Master's Degrees
  • News
    • Calls for applications
    • News
    • Events
  • Job vacancies
    • Job vacancies
    • Human Resources Strategy for Researchers of the European Commission (HRS4R)
  • Digital Platforms

MP11-Rheumatology

Precision Medicine / IBS-MP11 / Consolidated

ibs.GRANADA  ·  Research groups
  • Information
  • Members
  • Publications
  • Clinical trials

GROUP OBJECTIVE: Delve into the pathogenesis of rheumatoid arthritis. Genetic-molecular bases of rheumatoid arthritis: identification of genetic markers of predisposition and prognosis. To highlight its participation in National and International Projects of competitive financing, Collaboration in different projects with the SER/FER and the SAR/FAR, Collaboration in competitive financing projects with the Institute of Parasitology and Biomedicine López-Neyra (CSIC), with Centro of Genomics and Oncological Research (GENyO) and with the University of Granada.

Research lines

  • Biomarkers of prognosis and clinical course
  • Gene expression in autoimmune diseases
  • Response factors to biological therapies
  • Prognostic factors of evolution and therapeutic response
  • Cardiovascular morbidity
  • Polymorphisms in rheumatoid arthritis
  • Cardiovascular risk in autoimmune rheumatological diseases

Research networks

  • RIER - Research on Inflammation and Rheumatic Diseases

ISMAEL FRANCISCO AOMAR MILLAN

IMMACULATE JIMENEZ MOLEÓN

  • ORCID

PILAR MORALES GARRIDO

ENRIQUE RAYA ALVAREZ

  • ORCID

JUAN SALVATIERRA OSSORIO

  • ORCID

RICARDO SANCHEZ PARERA

  • ORCID
Ubeda, JR; Moleon, I.J. Alvarez, E.R.

Image in Osteology

JOURNAL OF OSTEOPOROSIS AND MINERAL METABOLISM, 2023;

Magouz, A; El-Kon, I; Raya-alvarez, E; Khaled, E; Alkhalefa, N; Alhegaili, AS; El-khadragy, MF; Agile, A; Elmahallawy, E.K.

Molecular typing of canine parvovirus type 2 by VP2 gene sequencing and restriction fragment length polymorphism in affected dogs from Egypt

FRONTIERS IN MICROBIOLOGY, 2023;

FI: 6,064; Q1

Aomar-Millán, IF; de Victoria-Carazo, JM; Reyes, DF; Torres-Parejo, U; Fernandez, LP; Martinez-Diz, S; Torres, AC; Gomez, JL; Bizzarri, F; Alvarez, ER; Salvatierra, J

Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids: A retrospective cohort study

PLOSONE, 2023;

FI: 3,7; Q2

Laiño-Piñeiro, MC; Rúa-Figueroa, I; Jiménez, N; Lozano, MJC; Martínez-Barrio, J; Serrano, B; Galindo-Izquierdo, M; Nack, A; Loricera, J; Tomero-Muriel, E; Ibáñez-Barceló, M; Vázquez, NM; Manrique-Arija, S; Lorenzo, NA; Narváez, J; Rosas, J; Menor-Almagro,

Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023;

FI: 5; Q2

Young, B; Manteca, CF; Rubio, E; Raya, E; Laziness; Hernandez, R; Manrique, S; Núñez, M; Díaz-Cerezo, S; Moyano, S; Lacetera, A; García-Vicuña, R

Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study

ADVANCES IN THERAPY, 2023;

FI: 3,8; Q3

Mena-Vazquez, N; Arija, SM; Rojas-Gimenez, M; Raya-Alvarez, E; Velloso-Feijoo, ML; Lopez-Medina, C; Ramos-Giraldez, C; Godoy-Navarrete, FJ; Redondo-Rodriguez, R; Cabezas-Lucena, AM; Morales-Aguila, M; Romero-Barco, CM; Fernandez-Nebro, A

Hospitalization and mortality from COVID-19 of patients with rheumatic inflammatory diseases in Andalusia

CLINICAL RHEUMATOLOGY, 2022;

Aouichat, S; Raya, E; Molina-Carballo, A; Munoz-Hoyos, A; Aloweidi, AS; Elmahallawy, EK; Agile, A.

Dose-Dependent Effect of Melatonin on BAT Thermogenesis in Zucker Diabetic Fatty Rat: Future Clinical Implications for Obesity

ANTIOXIDANTS, 2022;

FI: 7,675; D1

Fernandez-Diaz, C; Atienza-Mateo, B; Castaneda, S; Melero-Gonzalez, RB; Ortiz-SanJuan, F; Loricera, J; Casafont-Sole, I; Rodriguez-Garcia, S; Aguilera-Cros, C; Villa-Blanco, I; Raya-Alvarez, E; Ojeda-Garcia, C; Bonilla, G; Lopez-Robles, A; Arboleya, L; Narvaez, J; Cervantes, E; Corn, O; Alvarez-Rivas, MN; Heads, I; Salgado, E; Hidalgo-Calleja, C; Fernandez, S; Fernandez, JC; Ferraz-Amaro, I; Gonzalez-Gay, MA; White, R.

Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients

RHEUMATOLOGY, 2022;

FI: 7,046; Q1

Herrero-Morant, A; Martin-Varillas, JL; Castaneda, S; Corn, O; Sanchez, J; Ortego, N; Raya, E; Prior-Espanol, A; Moriano, C; Melero-Gonzalez, RB; Grana-Gil, J; Urruticoechea-Arana, A; Ramos-Calvo, A; Loredo-Martinez, M; Salgado-Perez, E; Sivera, F; Tower, I; Narvaez, J; Andreu, JL; Martinez-Gonzalez, O; Gomez-de la Torre, R; Fernandez-Aguado, S; Romero-Yuste, S; Gonzalez-Mazon, I; Alvarez-Reguera, C; Hernandez, JL; Gonzalez-Gay, MA; White, R.

Biologic therapy in refractory neurobehcet's disease: a multicentre study of 41 patients and literature review

RHEUMATOLOGY, 2022;

FI: 7,046; Q1

Aomar-Millan, IF; Salcaterra, J; Alvarez, E.R.

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia

CLINICAL MEDICINE, 2022;

FI: 3,2; Q2

Soret, P; LeDantec, C; Desvaux, E.; Foulquier, N.; Chassagnol, B; Hubert, S.; Jamin, C; Barturen, G; Desachy, G.; Devauchelle-Pensec, V; Boudjeniba, C; Cornec, D; Saraux, A; Jousse-Joulin, S; Barbarossa, N.; Rodriguez-Pinto, I; DeLanghe, E.; Beretta, L.; chizz

A new molecular classification to drive precision treatment strategies in primary Sjogren's syndrome.

NATURE COMMUNICATIONS, 2021;

FI: 14,919; D1

Barturen, G; Babaei, S; Catala-Moll, F; Martinez-Bueno, M; Makowska, Z; Martorell-Marugan, J; Carmona-Saez, P; Toro-Dominguez, D; Carnero-Montoro, E; Teruel, M; Kerick, M; Acosta-Herrera, M; Le Lann, L.; Jamin, C; Rodriguez-Ubreva, J; Garcia-Gomez, A; kage

Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases.

ARTHRITIS & RHEUMATOLOGY, 2021;

FI: 10,995; D1

Aomar-Millan, IF; Salvatierra, J.; Torres-Parejo, U; Faro-Miguez, N; Callejas-Rubio, JL; Ceballos-Torres, A; Cruces-Moreno, MT; Gomez-Jimenez, FJ; Hernandez-Quero, J; Anguita-Santos, F.

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study

INTERNAL AND EMERGENCY MEDICINE, 2021;

FI: 3,397; Q2

Aomar-Millan, IF; Salvatierra, J.; Hernandez-Quero, J.

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply..

INTERNAL AND EMERGENCY MEDICINE, 2021;

FI: 3,397; Q2

Riancho-Zarrabeitia, L; Martinez-Taboada, V; Rua-Figueroa, I; Alonso, F.; Galindo-Izquierdo, M; Ovalles, J.; Olive-Marques, A; Vazquez, NM; Calvo-Alen, J; Menor-Almagro, R; Tomero-Muriel, E; Uriarte-Isacelaya, E; Botenau, A; Andrew, M.; Freire-González, M; S

Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021;

FI: 4,473; Q2

Fernandez-Diaz, C; Castaneda, S; Melero-Gonzalez, RB; Ortiz-Sanjuan, F; Juan-Mas, A; Carrasco-Cubero, C; Casafont-Sole, I; Olive, A; Rodriguez-Muguruza, S; Almodovar-Gonzalez, R; Castellanos-Moreira, R; Rodriguez-Garcia, SC; Aguilera-Cros, C; Villa, I; gold

Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

RHEUMATOLOGY, 2020;

FI: 5,606; Q1

Torrente-Segarra, V; Salman-Monte, TC; Rua-Figueroa, I; del Campo, V; Lopez-Longo, FJ; Galindo-Izquierdo, M; Calvo-Alen, J; Olive-Marques, A; Mourino-Rodriguez, C; Horcada, L; Bohorquez, C; Montilla, C; Salgado, E; Diez-Alvarez, E; White, R; Andreu, JL;

Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER)

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020;

FI: 4,751; Q1

Rua-Figueroa, I; Lopez-Longo, FJ; Del Campo, V; Galindo-Izquierdo, M; Uriarte, E; Torre-Cisneros, J; Candle, P; Tomero, E; Narvaez, J; Olive, A; Freire, M; Salgado, E; Andreu, JL; Martinez-Taboada, V; Calvo-Alen, J; Hernandez-Cruz, B; Stripe, E; Quevedo, V; P

Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes

JOURNAL OF RHEUMATOLOGY, 2020;

FI: 3,35; Q2

Riancho-Zarrabeitia, L; Martinez-Taboada, V; Rua-Figueroa, I; Alonso, F; Galindo-Izquierdo, M; Ovalles, J; Olive-Marques, A; Fernandez-Nebro, A; Calvo-Alen, J; Minor-Almagro, R; Tomero-Muriel, E; Uriarte-Isacelaya, E; Botenau, A; Andres, M; Freire-Gonzale

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more accrual damage and higher mortality

LUPUS, 2020;

FI: 2,251; Q3

Cruz, BH; Alonso, F; Alen, JC; Pego-Reigosa, JM; Lopez-Longo, FJ; Galindo-Izquierdo, M; Olive, A; Tomero, E; Horcada, L; Uriarte, E; Erausquin, C; Sanchez-Atrio, A; Montilla, C; Soler, GS; Fernandez-Nebro, A; White, R; Rodriguez-Gomez, M; Candle, P; Freire

Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

LUPUS, 2020;

FI: 2,251; Q3

Lopez-Mejias, R; Carmona, FD; Genre, F; Remuzgo-Martinez, S; Gonzalez-Juanatey, C; Corrales, A; Vicente, EF; Pulito-Cueto, V; Miranda-Filloy, JA; Huaranga, MAR; White, R; Robustillo-Villarino, M; Rodriguez-Carrio, J; Alperi-Lopez, M; Alegre-Sancho, JJ; Mijares, V; Lera-Gomez, L; Perez-Pampin, E; Gonzalez, A; Ortega-Castro, R; Lopez-Pedrera, C; Vivar, MLG; Gomez-Arango, C; Stripe, E; Narvaez, J; Balsa, A; Lopez-Longo, FJ; Carreira, P; Gonzalez-Alvaro, I; Rodriguez-Rodriguez, L; Fernandez-Gutierrez, B; Ferraz-Amaro, I; Gualillo, O; Castaneda, S; Martin, J; Llorca, J; Gonzalez-Gay, MA

Identification of a 3 '-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

ARTHRITIS & RHEUMATOLOGY, 2019;

FI: 9,002; D1

Atienza-Mateo, B; Martin-Varillas, JL; Calvo-Rio, V; Demetrio-Pablo, R; Beltran, E; Sanchez-Burson, J; Mesquida, M; Adam, A; Hernandez, MV; Hernandez-Garfella, M; Valls-Pascual, E; Martinez-Costa, L; Sellas-Fernandez, A; Lamb-Eat, M; Diaz-Llopis, M; Gallego, R; Garcia-Serrano, JL; Ortego-Centeno, N; Herreras, JM; Fonollosa, A; Garcia-Aparicio, AM; Maiz-Alonso, O; White, A; Torre-Salaberri, I; Fernandez-Espartero, C; Jovani, V; Peiteado, D; Duck, E; Cruz, J; Fernandez-Cid, C; Aurrecoechea, E; Garcia-Arias, M; Castaneda, S; Caracuel-Ruiz, MA; Montilla-Morales, CA; Atanes-Sandoval, A; Francisco, F; Insua, S; Gonzalez-Suarez, S; Sanchez-Andrade, A; Gamero, F; Ferrando, LFL; Romero-Bueno, F; Garcia-Gonzalez, AJ; Gonzalez, RA; Muro, EM; Carrasco-Cubero, C; Olive, A; Prior, A; Vazquez, J; Ruiz-Moreno, O; Jimenez-Zorzo, F; Manero, J; Fernandez, SM; Fernandez-Carballido, C; Rubio-Romero, E; Pages, FA; de Miera, FJTS; Martinez, MG; Diaz-Valle, D; Longo, FJL; Nolla, JM; Alvarez, ER; Martinez, MR; Gonzalez-Lopez, JJ; Rodriguez-Cundin, P; Hernandez, JL; Gonzalez-Gay, MA; White, R

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behcet's Disease: National Multicenter Study of 177 Cases

ARTHRITIS & RHEUMATOLOGY, 2019;

FI: 9,002; D1

Calderon-Goercke, M; Loricera, J; Aldasoro, V; Castaneda, S; Villa, I; Humbria, A; Moriano, C; Romero-Yuste, S; Narvaez, J; Gomez-Arango, C; Perez-Pampin, E; Melero, R; Becerra-Fernandez, E; Revenga, M; Alvarez-Rivas, N; Galisteo, C; Sivera, F; Olive-Marques, A; del Buergo, M; Marena-Rojas, L; Fernandez-Lopez, C; Navarro, F; Stripe, E; Galindez-Agirregoikoa, E; Arca, B; Solans-Laque, R; Conesa, A; Hidalgo, C; Vazquez, C; Roman-Ivorra, J; Lluch, P; Manrique-Arija, S; Candle, P; Miguel, E; Torres-Martin, C; Nieto, J; Ordas-Calvo, C; Salgado-Perez, E; Luna-Gomez, C; de Miera, FJTS; Fernandez-Llanio, N; Garcia, A; Larena, C; Palmou-Fontana, N; Calvo-Rio, V; Prieto-Pena, D; Gonzalez-Vela, C; Corrales, A; Varela-Garcia, M; Aurrecoechea, E; Dos Santos, R; Garcia-Manzanares, A; Ortego, N; Fernandez, S; Ortiz-Sanjuan, F; Corteguera, M; Hernandez, JL; Gonzalez-Gay, MA; White, R

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019;

FI: 5,072; Q1

Ferreiro-Iglesias, A; Montes, A; Perez-Pampin, E; Canete, JD; Stripe, E; Magro-Checa, C; Vasilopoulos, Y; Caliz, R; Ferrer, MA; Young, B; Carreira, P; Balsa, A; Pascual-Salcedo, D; White, FJ; Moreno-Ramos, MJ; Manrique-Arija, S; Ordonez, MD; Alegre-Sancho, JJ; Narvaez, J; Navarro-Sarabia, F; Moreira, V; Value, L; Garcia-Portales, R; Marquez, A; Gomez-Reino, JJ; Martin, J; Gonzalez, A

Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

PLOSONE, 2019;

FI: 2,776; Q2

Ruiz-Limon, P; Ortega-Castro, R; Barbarossa, N; Perez-Sanchez, C; Jamin, C; Patino-Trives, AM; Luque-Tevar, M; Ibanez-Costa, A; Perez-Sanchez, L; de la Rosa, IA; Abalos-Aguilera, M; Jimenez-Gomez, Y; Calvo-Gutierrez, J; Font, P; Escudero-Contreras, A; Alarcon-Riquelme, ME; Collantes-Estevez, E; Lopez-Pedrera, C; Maranon, C; Le Lann, L; Varela, N; Muchmore, B; Dufour, A; Alvarez; Chizzolini, CCM; From Langhe ,; Gerl, V; De Groof, A; Ducreux, J; Trombetta, E; Li, T; Alvarez-Errico, D; Rao, S; Pers, JO; Beretta, L; AguilarQuesada, R; Aguirre-Zamorano, MA; Rubio, JLC; Castro-Villegas, MC; Cervera, R; Chizzolini, C; Collantes, E; Cornec, D; From Langhe, E; Devauchelle-Pensec, V; Espinosa, G; Roldan, MCF; Anjos, TG; Hiepe, F; Moleon, IJ; Jousse-Joulin, S; Lauwerys, B; Lopez-Berrio, A; Lories, R; Marovac, J; Meroni, PL; Miranda, B; Navarro-Linares, H; Ortega-Castro, R; Ortego, N; Pers, JO; Garrido, ER; Stripe, E; Fernandez, RR; Rodriguez-Pinto, I; Saraux, A

Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis

FRONTIERS IN IMMUNOLOGY, 2019;

FI: 4,716; Q2

Ortiz-Fernandez, L; Carmona, F.D.; Lopez-Mejias, R; Gonzalez-Escribano, MF; Lyons, PA; Morgan, A.W.; Sawalha, A.H.; Smith, KGC; Gonzalez-Gay, MA; Martin, J.

Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis

ANNALS OF THE RHEUMATIC DISEASES, 2018;

FI: 12,35; D1

Gonzalez-Serna, D; Ortiz-Fernandez, L; Vargas, S; Garcia, A; Stripe, E; Fernandez-Gutierrez, B; Lopez-Longo, FJ; Balsa, A; Gonzalez-Alvaro, I; Narvaez, J; Gomez-Vaquero, C; Sage, JM; Garcia-Portales, R; Gonzalez-Escribano, MF; Tolosa, C; Carreira, P; Kiemeney, L; Coenen, MJH; Witte, T; Schneider, M; Gonzalez-Gay, MA; Martin, J

Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus

SCIENTIFIC REPORTS, 2018;

FI: 4,122; Q1

Lopez-Rodriguez, R; Perez-Pampin, E; Marquez, A; White, FJ; Young, B; Carreira, P; Ferrer, MA; Caliz, R; Value, L; Narvaez, J; Canete, JD; Ordonez, MD; Manrique-Arija, S; Vasilopoulos, Y; Balsa, A; Pascual-Salcedo, D; Moreno-Ramos, MJ; Alegre-Sancho, JJ; Navarro-Sarabia, F; Moreira, V; Garcia-Portales, R; Stripe, E; Magro-Checa, C; Martin, J; Gomez-Reino, JJ; Gonzalez, A

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

PLOSONE, 2018;

FI: 2,766; Q1

Cea-Calvo, L; Stripe, E; Marras, C; Salman-Monte, TC; Ortiz, A; Salvador, G; Monteagudo, I; Carmona, L; Fernandez, S; Arteaga, MJ; Calvo-Allen, J

The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.

RHEUMATOLOGY INTERNATIONAL, 2018;

FI: 1,952; Q4

Cea-Calvo, L; Stripe, E; Marras, C; Salman-Monte, TC; Ortiz, A; Salvador, G; Monteagudo, I; Carmona, L; Fernandez, S; Arteaga, MJ; Calvo-Alen, J

The beliefs of rheumatoid arthritis patients in their subcutaneous biological drugs: strengths and areas of concern (vol 38, pg 1735, 2018)

RHEUMATOLOGY INTERNATIONAL, 2018;

FI: 1,952; Q4

Carmona, FD; Vaglio, A; Mackie, SL; Hernandez-Rodriguez, J; Monach, PA; Castaneda, S; Solans, R; Purple, IC; Narvaez, J; Ramentol-Sintas, M; Pease, CT; Dasgupta, B; Watts, R; Khalidi, N; Langford, CA; Ytterberg, S; Boiardi, L; Beretta, L; Govoni, M; Emmi, G; Bonatti, F; Cimmino, MA; Witte, T; Neumann, T; Holle, J; Schoenau, V; Sailler, L; Papo, T; Haroche, J; Mahr, A; Mouthon, L; Molberg, O; Diamantopoulos, AP; Voskuyl, A; Brouwer, E; Daikeler, T; Berger, CT; Molloy, ES; O'Neill, L; Blockmans, D; Lie, BA; Mclaren, P; Vyse, TJ; Wijmenga, C; Allanore, Y; Koeleman, BPC; Barrett, JH; Cid, MC; Salvarani, C; Merkel, PA; Morgan, AW; Gonzalez-Gay, MA; Martin, J

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

AMERICAN JOURNAL OF HUMAN GENETICS, 2017;

FI: 9,025; D1

Garcia-Gomez, C; Martin-Martinez, MA; Castaneda, S; Sanchez-Alonso, F; Uriarte-Ecenarro, M; Gonzalez-Juanatey, C; Romera-Baures, M; Santos-Rey, J; Pinto-Tasende, J.A.; Quesada-Masachs, E; Tornero-Molina, J; Martinez-Gonzalez, O; Cobo-Ibanez, T; Chamizo-Carmona, E; Manrique-Arija, S; Fabregas-Canales, D; Diaz-Gonzalez, F; Llorca, J; Gonzalez-Gay, MA

Lipoprotein (a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

JOURNAL OF CLINICAL LIPIDOLOGY, 2017;

FI: 5,812; D1

Garcia-Rodriguez, S; Arias-Santiago, S; Blasco-Morente, G; Orgaz-Molina, J; Rosal-Vela, A; Navarro, P; Magro-Checa, C; Martinez-Lopez, A; Ruiz, JC; Stripe, E; Naranjo-Sintes, R; Sancho, J; Zubiaur, M

Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017;

FI: 3,528; Q1

Lopez-Mejias, R; Corrales, A; Vicente, E; Robustillo-Villarino, M; Gonzalez-Juanatey, C; Llorca, J; Genre, F; Remuzgo-Martinez, S; Dierssen-Sotos, T; Miranda-Filloy, JA; Huaranga, MAR; Pina, T; White, R; Alegre-Sancho, JJ; Stripe, E; Mijares, V; Ubilla, B; Ferraz-Amaro, I; Gomez-Vaquero, C; Balsa, A; Lopez-Longo, FJ; Carreira, P; Gonzalez-Alvaro, I; Ocejo-Vinyals, JG; Rodriguez-Rodriguez, L; Fernandez-Gutierrez, B; Castaneda, S; Martin, J; Gonzilez-Gay, MA

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

SCIENTIFIC REPORTS, 2017;

FI: 4,259; Q1

Rua-Figueroa, I; Lopez-Longo, J; Galindo-Izquierdo, M; Calvo-Alen, J; Del Campo, V; Olive-Marques, A; Perez-Vicente, S; Fernandez-Nebro, A; Andres, M; Erausquin, C; Tomero, E; Horcada, L; Uriarte, E; Freire, M; Montilla, C; Sanchez-Atrio, A; Santos, G; Boteanu, A; Diez-Alvarez, E; Narvaez, J; Martinez-Taboada, V; Silva-Fernandez, L; Ruiz-Lucea, E; Andreu, JL; Hernandez-Beriain, JA; Gantes, M; Hernandez-Cruz, B; Perez-Venegas, J; Pecondon-Espanol, A; Marras, C; Ibanez-Barcelo, M; Bonilla, G; Torrente, V; Castellvi, I; Alegre, JJ; Calvet, J; Marenco, JL; Stripe, E; Vazquez, T; Quevedo, V; Munoz-Fernandez, S; Rodriguez-Gomez, M; Ibanez, J; Pego-Reigosa, JM

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017;

FI: 4,498; Q1

Zhao, M; Zhou, Y; Zhu, BC; Wan, MJ; Jiang, TT; Tan, QQ; Liu, Y; Jiang, JQ; Luo, SHT; Tan, YX; Wu, HJ; Renauer, P; Gutierrez, MDA; Palma, MJC; Castro, RO; Fernandez-Roldan, C; Stripe, E; Faria, R; Carvalho, C; Alarcon-Riquelme, ME; Xiang, ZY; Chen, JW; Li, F; Ling, GH; Zhao, HJ; Liao, XP; Lin, YK; Sawalha, AH; Lu, QJ

IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus

ANNALS OF THE RHEUMATIC DISEASES, 2016;

FI: 12,384; D1

Lopez-Mejias, R; Genre, F; Remuzgo-Martinez, S; Gonzalez-Juanatey, C; Robustillo-Villarino, M; Llorca, J; Corrales, A; Vicente, E; Miranda-Filloy, JA; Lean, C; Tejera-Segura, B; Huaranga, MAR; Pina, T; White, R; Alegre-Sancho, JJ; Stripe, E; Mijares, V; Ubilla, B; Sanchez, MDM; Gomez-Vaquero, C; Balsa, A; Pascual-Salcedo, D; Lopez-Longo, FJ; Carreira, P; Gonzalez-Alvaro, I; Rodriguez-Rodriguez, L; Fernandez-Gutierrez, B; Ferraz-Amaro, I; Castaneda, S; Martin, J; Gonzalez-Gay, MA

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

SCIENTIFIC REPORTS, 2016;

FI: 5,228; Q1

Pego-Reigosa, JM; Lois-Iglesias, A; Rua-Figueroa, I; Galindo, M; Calvo-Alen, J; by Una-Alvarez, J; Balboa-Barreiro, V; Ruan, JI; Olive, A; Rodriguez-Gomez, M; Nebro, AF; Andres, M; Erausquin, C; Tomero, E; Rubio, LH; Isacelayam, USA; Freire, M; Montilla, C; Sanchez-Atrio, AI; Santos-Soler, G; Zea, A; Ten, E; Narvaez, J; Blanco-Alonso, R; Silva-Fernandez, L; Ruiz-Lucea, ME; Fernandez-Castro, M; Hernandez-Beriain, JA; Gantes-Mora, M; Hernandez-Cruz, B; Perez-Venegas, J; Pecondon-Espanol, A; Fernandez-Cid, CM; Ibanez-Barcelo, M; Bonilla, G; Torrente-Segarra, V; Castellvi, I; Alegre, JJ; Calvet, J; de la Fuente, JLM; Stripe, E; Vazquez-Rodriguez, TR; Quevedo-Vila, V; Munoz-Fernandez, S; Oton, T; Rahman, A; Lopez-Longo, FJ

Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyzes in a large cohort from the Spanish Society of Rheumatology Lupus Registry

RHEUMATOLOGY, 2016;

FI: 4,524; Q1

Ferreiro-Iglesias, A; Montes, A; Perez-Pampin, E; Canete, JD; Stripe, E; Magro-Checa, C; Vasilopoulos, Y; Sarafidou, T; Caliz, R; Ferrer, MA; Young, B; Carreira, P; Balsa, A; Pascual-Salcedo, D; White, FJ; Moreno-Ramos, MJ; Fernandez-Nebro, A; Ordonez, MC; Alegre-Sancho, JJ; Narvaez, J; Navarro-Sarabia, F; Moreira, V; Value, L; Garcia-Portales, R; Marquez, A; Martin, J; Gomez-Reino, JJ; Gonzalez, A

Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

PHARMACOGENOMICS JOURNAL, 2016;

FI: 3,784; Q1

Gomez, MMM; Montane, E; Arellano, AL; Olive, A.

Tacrolimus-induced gynecomastia in a patient with polymyositis

CLINICAL MEDICINE, 2016;

FI: 1,267; Q2

Real-life effectiveness of upadacitinib for early and sustained pain relief in radiographic axial spondyloarthritis (UPSTAND)

Funder: ABBVIE SPAIN SLU

Type of test: OBSERVATIONAL STUDY WITH MEDICATION

Execution time: 16/03/2023 - 30/06/2025

PI: ENRIQUE RAYA ALVAREZ

Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pegozafermin in patients with severe hypertriglyceridemia (HTGG). ENTRUST

Funder: 89BIO INC

Type of test: CLINICAL TRIAL WITH DRUGS

Execution time: 12/09/2023 - 30/12/2024

IP: ISMAEL FRANCISCO AOMAR MILLAN

“Prospective, randomized, multicenter study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the prevention of new morphometric vertebral fractures and/or aggravation of previous vertebral fractures in women with clinical vertebral fracture or recent hip fracture (imminent risk of fracture) and low bone mineral density. IMMINENT Study

Financier: GEDEON RICHTER IBÉRICA SA

Type of test: COMMERCIAL CLINICAL TRIAL

Execution time: 14/06/2022 - 30/12/2023

PI: ENRIQUE RAYA ALVAREZ

A multinational, noninterventional study of tofacitinib in patients treated for psoriatic arthritis. TOPSATI. PFI-TOF-2020-01

Financier: PFIZER HOLDING FRANCE

Type of test: OBSERVATIONAL STUDY WITH MEDICATION

Execution time: 03/08/2022 - 30/01/2024

PI: ENRIQUE RAYA ALVAREZ

Evaluation of guselkumab (Tremfya®) and treatment with different IL-17 inhibitors in patients with psoriatic arthritis in routine clinical practice; cohort, observational and prospective study.

Funder: JANSSEN-CILAG INTERNATIONAL NV

Type of test: COMMERCIAL POST AUTHORIZATION STUDY

Execution time: 19/11/2021 - 30/10/2027

PI: ENRIQUE RAYA ALVAREZ

Biological PsA: Retrospective observational study on anti-IL17 treatment patterns in the management of psoriatic arthritis. LIL-IXE-2020-01 (LY2439821)

Financier: LILLY, SA

Type of test: COMMERCIAL POST AUTHORIZATION STUDY

Execution time: 06/10/2020 - 30/01/2021

PI: ENRIQUE RAYA ALVAREZ

Observational study of the persistence of treatment in psoriasic arthritis PRO-SPIRIT study. (LIL-IXE-2019-01)

Funder: ELI LILLY AND COMPANY

Type of test: COMMERCIAL POST AUTHORIZATION STUDY

Execution time: 20/10/2020 - 30/12/2025

PI: ENRIQUE RAYA ALVAREZ

facebook icon twitter icon LinkedIn icon whatsapp icon

Responsible researcher

ENRIQUE RAYA ALVAREZ

  • enriqueg.raya.sspa@juntadeandalucia.es
  • ORCID

Research

  • Collaboration network between groups of the ibs.GRANADA
  • Oncology Area
  • Epidemiology and Public Health Area
  • Precision Medicine Area
  • Advanced Therapies and Biomedical Technologies Area
  • Clinical research

Post navigation

MP10-Translational Bioinformatics
MP12-Otology and Otoneurology

ibs.Granada logo

  • info@ibsgranada.es
  • Avda. De Madrid, 15
    External Consultation Pavilion, 2nd Floor
    18012 Grenada.
  • facebook icon
  • twitter icon
  • instagram icon
  • linkedin icon
  • youtube icon
University of Granada
Investigate +
© 2025 ibs.GRENADA
  • Legal Notice
  • Cookies Policy
  • Privacy Policy
  • Contact
  • Site map

We use cookies to offer you the best experience on our website.

You can learn more about which cookies we use or deactivate them in the .

X
ibs logo.GRANADA
Powered by  GDPR Cookie Compliance
Privacy summary

This website uses cookies so that we can offer you the best possible user experience. The information of the cookies is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.

Technical and necessary cookies

The strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

If you deactivate this cookie we will not be able to save your preferences. This means that every time you visit this website you will have to activate or deactivate cookies again.

Analytics and optimization

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Please activate the strictly necessary cookies first so that we can save your preferences!

Cookies policy

More information about our Cookies policy